Syndicated Omni-Channel report on Rheumatology (Wave 1) - USA

Reports go beyond channel mix to unearth the value and unmet needs in engagements.

Engage reports aim to support pharmaceutical companies in this current (post) pandemic market scenario. Enabling you to closely track your customers' channel habits and competitors to boost your customer engagement strategy, identify potential opportunities and mitigate business risks.

Over 40 channels tracked consisting of Pharma owned sources, professional and educational sources, and other web and social sources.

Key questioned answered:

• What is the current mix of channel use? What does the ideal look like?

• Which channels serve which purpose for HCPs?

• Which areas fall short in HCP needs when seeking information to aid their practice?

• What do HCPs value in information searching and is pharma meeting this?

• Which information channels are considered most valued, trustworthy, and influential?

• Who is offering high-quality interactions that leave customers feeling satisfied?

• If pharma want to engage with HCPs in the most meaningful way, which channels should be used?

• How should pharma flex their communication strategy based on HCP traits and needs?

• Which emerging channels are being used effectively?

What your report will deliver:

• Report covering USA with country differences highlighted

• Upfront insightful summary and recommendations

• Actions highlighted where impactful engagements can be enhanced

• Video outputs embedded in the report to bring the findings to life

• HCP segmentation based not only on demographic metrics but also attitudinal statements

Enabling you to:

• Understand your customers digital and traditional information seeking habits and their evolution over time

• Effectively allocate your marketing and communication budgets to maximize impact

• Structure, manage and continuously refine your engagement strategies